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Simple Summary: Antimicrobial resistance (AMR) is a public health concern. Increasing resistance
has arisen due to the inappropriate use of antimicrobial drugs in both, human and veterinary
medicine. Although AMR is mainly linked to direct and indirect human activities, little is known
about the presence and impact that AMR has on wild animals, especially for those bound to habitats
subjected to little human pressure. Our study analyzed the AMR profiles of different Pasteurellaceae
species obtained from the infected lungs of Pyrenean chamois (Rupicapra pyrenaica) and domestic
sheep found in a National Hunting Reserve from Spain. We have found evidence of the presence
of AMR in both animal species. Furthermore, some isolates were resistant to cephalosporins and
fluoroquinolones, which are antimicrobials of critical importance in human medicine. Further
research is needed to discern pathways of AMR dissemination within natural environments and
assess its persistence in wildlife in order to prevent further AMR spreading at a global scale.
Abstract: Antimicrobial resistance (AMR) has spread worldwide due to the inappropriate use of
antimicrobial drugs in human and veterinary medicine, becoming a public health problem. However,
little is known about its occurrence and maintenance in wild animals, and very few studies have
been carried out in ecosystems subjected to low human pressure. In our study, nasal and lung
swabs were collected from hunted Pyrenean chamois (Rupicapra pyrenaica), and nasal swabs from
sympatric domestic sheep were also collected. The swabs were cultured in agar plates to obtain
bacterial isolates from the Pasteurellaceae family. The presence of AMR was assessed in a total of
28 Pasteurellaceae isolates from 45 Pyrenean chamois, and 9 isolates from sympatric domestic sheep
found in the National Hunting Reserve of Freser-Setcases (Northeastern Pyrenees, Spain). The
isolates belonged to one of the following three species: Pasteurella multocida, Mannheimia haemolytica
and Bibersteinia trehalosi. Some P. multocida and M. haemolytica isolates tested positive for AMR. The
statistical analysis revealed no differences between the AMR levels from chamois and domestic sheep
isolates. However, one P. multocida of chamois origin presented resistance to cephalosporins and
fluoroquinolones, which are antibiotics of critical importance for human health. Further studies are
required to elucidate potential routes of dissemination of AMR genes in natural environments and
assess any significant persistence in wildlife to design risk mitigation actions.
Keywords: antimicrobial resistance; chamois; wildlife; Pasteurellaceae; Rupicapra pyrenaica; wildlife–
livestock interface
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1. Introduction
Antimicrobial resistance (AMR) is a natural phenomenon; most antimicrobial agents
are produced by free-living fungi, plants and bacterial species that are present in all envi-
ronments, enabling them to fight infections and directly compete for ecological niches [1].
The genes conferring resistance to antimicrobial drugs are positively selected in microbial
populations under the environmental pressure of these compounds [2]. The excessive
and inappropriate use of antimicrobial agents by humans has led to the selection, emer-
gence and spread of multidrug resistance in both pathogenic and commensal bacteria [3,4].
Moreover, antimicrobial drugs can persist in soil and aquatic environments, exercising also
selective pressure over bacteria in these environments [5,6].
The emergence of AMR in both Gram-positive and Gram-negative bacteria has re-
sulted in difficult-to-treat or untreatable infections, an increase in morbidity and mortality,
and an increase in the costs of treating infectious diseases [7,8]. These factors have turned
AMR into one of the main public health concerns worldwide [9,10]. Overall, the World
Health Organization (WHO) has foreseen the beginning of a post-antimicrobial era [11].
Despite the importance of AMR, its occurrence and maintenance in wild animals is
poorly understood. Antibiotic-resistant bacteria have already been described in different
species [12,13]. AMR in wildlife can be a public health concern if associated with zoonotic
pathogens that are transmissible from wildlife to humans, or vice versa. Wildlife may
also provide a mechanism for the spread and maintenance of resistance genes into natural
systems [3], and for predicting the emergence of resistant pathogens [9]. Therefore, wildlife
has been proposed as a good sentinel to locally monitor and predict the emergence of
AMR [9].
The study of AMR occurrence in remote habitats, or in ecosystems subjected to
limited human influence, can help to identify levels of AMR in natural environments
and assess how anthropogenic activities are influencing AMR in bacterial populations
worldwide [14,15]. There are a few studies carried out in such isolated environments, for
instance the Antarctica [15–17] or in alpine ecosystems [18].
Up to date, most of the studies on AMR and wildlife have focused on Enterococci [9],
Enterobacteriaceae [19,20], Campylobacter spp., Listeria monocytogenes [20], or even methicillin-
resistant Staphylococcus aureus [21]. Yet, very few studies have focused on the bacteria
involved in respiratory infections, such as those belonging to the family Pasteurellaceae.
The aim of this study was to assess the antimicrobial susceptibility profile of the bacte-
ria involved in respiratory infections of the Pasteurellaceae family, isolated from sympatric
Pyrenean chamois (Rupicapra pyrenaica) and domestic sheep that graze in alpine meadows.
These studies are vital to establish baseline data of AMR occurrence and assess their extent
in an area with a priori low human influence.
2. Materials and Methods
2.1. Study Area
The present study was performed in the Freser-Setcases National Game Reserve
(FSNGR) in the Pyrenees, Northeastern Spain. This area is a high mountain habitat with
strong seasonal influence and is mainly composed of alpine and subalpine ecosystems.
Pyrenean chamois is the most abundant ungulate species, although mouflon (Ovies aries
musimon), roe deer (Capreolus capreolus), red deer (Cervus elaphus) and wild boar (Sus scrofa)
also occur in much lower numbers. Domestic ruminants, including domestic sheep, cattle
and horses, also dwell with the wild ungulates during the grazing period from May to
November [22].
2.2. Sample Collection and Processing
Between 2015 and 2017, a total of 37 Pasteurellaceae isolates were obtained from pneu-
monic lesions in Pyrenean chamois (n = 45) legally hunted in FSNGR during the regular
hunting season (August–November), and from nasal swabs of domestic sheep (n = 24) in
two flocks that seasonally graze at FSNGR.
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For each sampled Pyrenean chamois, both nasal and lung swabs with Amies transport
medium were collected. In the case of domestic sheep, a single nasal swab with Amies
transport medium was also collected. All swabs were carefully labeled and stored at 4 ◦C
and processed in the lab within the first 24 h post-collection. Amies swabs were cultured
on Polivytex agar plates (Biomerieux, Madrid, Spain) and incubated for 48 h at 37 ◦C
and 5% CO2 [23]. Macroscopic morphologically compatible colonies with Pasteurellaceae
were replated to obtain a pure culture and were further identified using a 16S rRNA PCR,
following previously described protocols [24]. The positive controls used for the PCR were
from a P. multocida isolate Sanger-sequenced from our strain collection. Isolates that were
confirmed to belong to the family Pasteurellaceae were then stored in 20% glycerol/brain
heart infusion (BHI; Oxoid) at −80 ◦C until further analysis.
2.3. Minimum Inhibitory Concentration (MIC)
MIC was determined by microbroth dilution method (Thermo ScientificTM SensititreTM,
Waltham, MA, USA) following the Clinical Laboratory Standards Institute guidelines
(CLSI, Wayne, PA, USA, 2018). Antimicrobials and concentrations tested were as follows:
chlortetracycline (0.5–8 µg/mL), oxytetracycline (0.5–8 µg/mL), gentamicin (1–16 µg/mL),
spectinomycin (8–64 µg/mL), neomycin (4–32 µg/mL), florfenicol (0.25–8 µg/mL), peni-
cillin (0.12–8 µg/mL), ampicillin (0.25–16 µg/mL), ceftiofur (0.25–8 µg/mL), danofloxacin
(0.12–1 µg/mL), enrofloxacin (0.12–2 µg/mL), sulphadimethoxine (256 µg/mL), trimetho-
prim/sulfamethoxazole (2/38 µg/mL), tylosin tartrate (0.5–4 µg/mL), tulathromycin
(1–64 µg/mL), tilmicosin (4–64 µg/mL), clindamycin (0.25–16 µg/mL) and tiamulin
(1–32 µg/mL). MIC determinations and clinical breakpoints were used in accordance
with criteria provided by the CLSI (CLSI, Wayne, PA, USA, 2018). Multidrug resistance
was defined as resistance to three or more families of antimicrobials [25].
2.4. Statistical Analysis
Fisher’s exact tests were applied in order to evaluate statistical differences between
resistance found in bacterial species, and whether resistance was related to animal species.
Pairwise Test of Independence for nominal data was applied as a post-hoc test. The p-values
were considered statistically significant when below 0.05 (p < 0.05). Bibersteinia trehalosi was
not included on the statistical analysis due to a lack of representative samples and absence
of data regarding MIC breakpoints. For the statistical analysis, an isolate was considered
resistant when it presented resistance to at least 1 antimicrobial family. Factors included
in the statistical model were animal species, bacteria species, and resistance profile. The
statistical analysis was performed using the R 3.3.3 program [26].
3. Results
In total, 20 Pasteurella multocida (19 from chamois and 1 from sheep), 14 Mannheimia
haemolytica (6 from chamois and 8 from sheep) and three Bibersteinia trehalosi from chamois
were isolated (Table 1).
Among the P. multocida isolates in Pyrenean chamois (n = 19), 10.5% were resistant to
ampicillin, 10.5% to penicillin and 5.2% to ceftiofur. Additionally, intermediate resistance
was detected for enrofloxacin (5.3%), spectinomycin (5.36%) and florfenicol (5.3%) (Table 2,
MIC values in Supplementary Table S1). One P. multocida of chamois origin was multidrug
resistant, exhibiting resistance to beta-lactams, fluoroquinolones and phenicols. All of
the M. haemolytica isolates of chamois (n = 6) were pansusceptible (Table 3, MIC values
in Supplementary Table S2). Neither the clinical breakpoints nor epidemiological cut-
off values have been described for B. trehalosi by CLSI or the European Committee on
Antimicrobial Susceptibility Testing (EUCAST), yet the MIC results obtained for our isolates
belonging to this species are displayed on Supplementary Table S3.
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Table 1. Number of antimicrobial resistance (AMR) detected divided by bacteria species and animal
species. We considered that AMR was present if an isolate showed intermediate or total resistance
to a specific antimicrobial family, following MIC criteria from CLSI guidelines. Considered an-
tibiotics are ceftiofur, penicillin, ampicillin, danofloxacin, enrofloxacin, tulathromycin, tilmicosin,
chlortetracycline, oxytetracycline, spectinomycin and florfenicol.
Bacteria
Chamois Sheep All
Analyzed AMR * Analyzed AMR Analyzed AMR
Pasteurella multocida 19 7 1 0 20 7
Mannheimia haemolytica 6 1 8 5 14 6
Bibersteinia trehalosi 3 - - - - -
Total 28 8 9 5 37 13
* Minimum inhibitory concentration (µg/mL), established by the CLSI guidelines: ceftiofur: ≥8 Pm/≥8 Mh, peni-
cillin: ≥1 Pm/≥1 Mh, ampicillin: ≥0.25 Pm/≥0.25 Mh, danofloxacin: ≥1 Pm/≥1 Mh, enrofloxacin: ≥2 Pm/≥2 Mh,
tulathromycin: ≥64 Pm/≥64 Mh, tilmicosin: ≥32 Pm/≥32 Mh, chlortetracycline: ≥8 Pm/≥8 Mh, oxytetracycline:
≥8 Pm/≥8 Mh, spectinomycin: ≥128 Pm /≥128 Mh and florfenicol: ≥8 Pm/≥8 Mh. XPm: MIC value for Pasteurella
multocida; XMh: MIC value for Mannheimia haemolytica.
Table 2. Number of Pasteurella multocida isolates found in chamois and domestic sheep, classified
as susceptible (S), intermediate (I) or fully resistant (R) to the antibiotics tested. We considered that
AMR was present if an isolate showed intermediate or total resistance to a specific antimicrobial
family, following MIC criteria from CLSI guidelines. Considered antibiotics are ceftiofur, penicillin,
ampicillin, danofloxacin, enrofloxacin, tulathromycin, tilmicosin, chlortetracycline, oxytetracycline,
spectinomycin and florfenicol.
P. multocida. N = 20 (RP = 19, OA = 1)
Antimicrobial Family Antimicrobial Agent Species S (%) I (%) R (%)
Cephalosporins Ceftiour
RP 94.7 0 5.3
OA 100 0 0
Penicillins
Penicillin
RP 89.47 0 10.53
OA 100 0 0
Ampicillin
RP 89.57 0 10.5
OA 100 0 0
Fluoroquinolones
Danofloxacin
RP 100 0 0
OA 100 0 0
Enrofloxacin
RP 94.74 5.3 0
OA 100 0 0
Macrolides
Tulathromycin
RP 100 0 0
OA 100 0 0
Tilmicosin
RP 100 0 0
OA 100 0 0
Tylosin tartrate
RP - - -
OA - - -
Tetracyclines
Chlortetracycline
RP 100 0 0
OA 100 0 0
Oxytetracycline
RP 100 0 0
OA 100 0 0
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Table 2. Cont.
P. multocida. N = 20 (RP = 19, OA = 1)
Antimicrobial Family Antimicrobial Agent Species S (%) I (%) R (%)
Aminoglycosides
Gentamicin
RP - - -
OA - - -
Neomcyin
RP - - -
OA - - -
Spectinomycin
RP - - -
OA - - -
Fenicols Florfenicol
RP 94.7 5.3 0
OA 100 0 0
Sulphonamides
Sulphadimetoxine
RP - - -
OA - - -
Trimetroprim/Sulfametoxazole
RP - - -
OA - - -
Lincosamides
Clindamycin
RP - - -
OA - - -
Tiamulin
RP - - -
OA - - -
N: sample size. RP: Rupicapra pyrenaica (chamois); OA: Ovis aries (domestic sheep). NA: not calculated due to the
absence of CLSI established breakpoints.
Table 3. Number of Mannheimia haemolytica isolates found in chamois and domestic sheep, classified
as susceptible (S), intermediate (I) or fully resistant (R) to the antibiotics tested. We considered that
AMR was present if an isolate showed intermediate or total resistance to a specific antimicrobial
family, following MIC criteria from CLSI guidelines. Considered antibiotics are ceftiofur, penicillin,
ampicillin, danofloxacin, enrofloxacin, tulathromycin, tilmicosin, chlortetracycline, oxytetracycline,
spectinomycin and florfenicol.
M. haemolytica N = 14 (RP = 6, OA = 8)
Antimicrobial Family Antimicrobial Agent Species S (%) I (%) R (%)
Cephalosporins Ceftiour
RP 100 0 0
OA 100 0 0
Penicillins
Penicillin
RP 100 0 0
OA 87.50 12.50 0
Ampicillin
RP 100 0- 0
OA 100 - -
Fluoroquinolones
Danofloxacin
RP 100 0 0
OA 87.50 0 12.50
Enrofloxacin
RP 100 0 0
OA 87.50 12.50 0
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Table 3. Cont.
M. haemolytica N = 14 (RP = 6, OA = 8)
Antimicrobial Family Antimicrobial Agent Species S (%) I (%) R (%)
Macrolides
Tulathromycin
RP 100 0 0
OA 87.50 0 12.50
Tilmicosin
RP 100 0 0
OA 100 0 0
Tylosin tartrate
RP - - -
OA - - -
Tetracyclines
Chlortetracycline
RP 100 0 0
OA 100 0 0
Oxytetracycline
RP 100 0 0
OA 100 0 0
Aminoglycosides
Gentamicin
RP - - -
OA - - -
Neomcyin
RP - - -
OA - - -
Spectinomycin
RP 100 0 0
OA 100 0 0
Fenicols Florfenicol
RP 100 0 0
OA 100 0 0
Sulphonamides
Sulphadimetoxine
RP - - -
OA - - -
Trimetroprim/Sulfametoxazole
RP - - -
OA - - -
Lincosamides
Clindamycin
RP - - -
OA - - -
Tiamulin
RP - - -
OA - - -
N: sample size. RP: Rupicapra pyrenaica (chamois); OA: Ovis aries (domestic sheep). -: not calculated due to the
absence of CLSI established breakpoints.
The statistical analysis revealed no significant differences in the AMR profiles between
bacterial species or animal species (chamois and sheep).
4. Discussion
Monitoring AMR in geographic areas with a relatively low level of human influ-
ence provides a suitable system for studying AMR in natural habitats. Surprisingly, the
isolates from Pasteurellaceae obtained from chamois exhibited similar levels of resistance
to several antimicrobial agents used in human and animal health, such as beta-lactams
and macrolides. Furthermore, this is the first report of resistance to a third-generation
cephalosporin (ceftiofur) in a P. multocida isolate of wildlife origin. The bacteria from the
Pasteurellaceae family can acquire resistance to antimicrobials by mutations or horizontal
gene transfer from different sources, including other bacteria species. In this regard, mobile
genetic elements, such as plasmids or transposons, are the main elements that contribute
to the dissemination of AMR, and Pasteurellaceae can act as both receptors and donors
of these genetic elements [27]. In fact, resistance to cephalosporin is usually determined
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by the presence of extended-spectrum beta-lactamases (ESBLs). It is difficult to elucidate
the origin of this resistance phenotype since these chamois are not subjected to an AMR-
selective environment. Recent studies have found that AMR is a multifactorial problem,
with intrinsic links between the human, animal and environmental interface. It has been
demonstrated that interactions between those three settings allow the movement not only
of bacteria, but also of antimicrobial resistance genes (ARGs). Environmental factors, such
as water and soil, can serve as pools of ARGs. Additionally, given the high use of antibiotics
in farm animals in Europe, the sympatric sheep could have acted as carriers of AGRs [28].
However, it is worth pointing out that most of the studies in the literature are focused
on Enterobacteriaceae, rather than respiratory-related bacteria. In general, AMR levels in
Pasteurellaceae from domestic animal species have shown to be low but with an increasing
tendency [27,29].
In our case, interactions between livestock and chamois may occasionally occur in
alpine meadows [30], and seasonal AMR transmission between domestic and wild un-
gulates cannot be excluded. The potential sources of interaction between the Pyrenean
chamois and domestic sheep could include the supplementation of salt or even the presence
of domestic sheep feces within the pastures. It is also unclear the role that the environment
plays in our scenario as a potential reservoir for ARGs, as it has been proposed for Enter-
obacteriaceae. However, there are a lack of studies based in other species and further work
should be designed to unravel possible ARGs transmission routes between respiratory
bacteria and the environmental pool of ARGs.
The most common antibiotics used to treat respiratory infections in domestic rumi-
nants include ceftiofur, tulathromycin (macrolide), sulfonamides, tetracyclines, strepto-
mycin and florfenicol [29,31]. The finding of a cephalosporin-resistant isolate is interesting
since third and fourth-generation cephalosporins are considered “critically important” an-
tibiotics in human medicine [32,33]. Furthermore, resistance to ceftiofur has been described
in recent years in P. multocida from cattle origin [34]. P. multocida isolates analyzed herein
exhibited similar AMR profiles to those described from cattle in Europe [30]; in general,
a low level of resistance to all antimicrobials with increasing resistance to florfenicol and
spectinomycin. El Garch et al. (2016) [35] also reported susceptibility to florfenicol and
increased resistance to spectinomycin in cattle.
Studies focusing on P. multocida and M. haemolytica described rising numbers of AMR
worldwide in food-producing animals [30]. In agreement with our data, M. haemolytica
typically exhibited more resistance than P. multocida. Although our results did not show
statistical significance regarding resistance profiles between M. haemolyitica isolated from
chamois and sheep, resistance to danofloxacin and tulathromycin was detected in sheep
isolates, probably as a result of antimicrobial drug usage during rearing.
Finally, the number of isolates of B. trehalosi obtained in this study is too small to get
to any conclusive results. However, considering the lack of information in the literature
regarding AMR for this bacterial species and the lack of clinical breakpoints, the results
from this study contribute as valuable reference for further studies.
5. Conclusions
In conclusion, AMR levels found in the Pasteurellaceae isolates from wild and domestic
animals in an alpine ecosystem from Northeastern Spain are consistent with that described
in other livestock from Europe. The similar frequency of AMR detection in isolates from
chamois may indicate an indirect anthropogenic influence for the AMR spread in these
ecosystems. Furthermore, we report the presence of cephalosporin and fluoroquinolone
resistant isolates, which are antimicrobials of clinical importance for human health. Further
studies are needed to elucidate potential routes of dissemination of AMR genes in natural
environments and assess any significant persistence in wildlife in order to implement risk
mitigation actions.
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Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ani11061686/s1, Table S1: MIC distribution frequencies of Pasteurella multocida isolates,
Table S2: MIC distribution frequencies of Mannheimia haemolytica isolates, Table S3: MIC distribution
frequencies of Biberstenia trehalosi isolates from Pyrenean chamois.
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